St Marys Hospital Ingrid V. Bassett, MD, MPH Massachusetts General Hospital Harvard Medical School May 25, 2010 Who Starts ART in Durban, South Africa?

Slides:



Advertisements
Similar presentations
HIV Counseling, Testing and Referral (CTR) Services at Boston Medical Center Vanessa J. Sasso, MSW Manager, HIV CTR Program Center for HIV/AIDS Care and.
Advertisements

OPTN Modifications to Heart Allocation Policy Implemented July 12, 2006 Changed the allocation order for medically urgent (Status 1A and 1B) patients Policy.
Scaling up HIV services for women and children achievements and challenges e-lluminate session e-lluminate session Yves Souteyrand 2 March 2010.
Slide 1 Healthcare Utilization and Mortality associated with HIV and HCV: How to address the burden of liver disease Susanna Naggie 1,2, Lawrence Park.
HEART TRANSPLANTATION Overall ISHLT 2008 J Heart Lung Transplant 2008;27:
CURRENT ISSUES IN TB (& HIV) Marc Lipman 8 September 2011.
1 TREATMENT AND PREVENTION SCALE-UP: THE SOUTH AFRICAN EXPERIENCE By Dr Moolman Team South Africa.
ART SERVICES SCALE UP IN NIGERIA SUCCESSES CHALLENGES and WAY FORWARD TEAM NIGERIA.
Group III: Demand Forecasting
Nick Curry, MD, MPH Infectious Diseases Prevention Section
How Universal will Universal Access be in Europe by 2010? Eddy Beck Evaluation Department UNAIDS, Geneva
Thailands experience with using program data to improve PMTCT strategies and outcomes. Sarawut Boonsuk, MD. MPH Chief of MCH, Bureau of Health Promotion.
Antiretroviral Therapy: An HIV Prevention Strategy? Wafaa El-Sadr, MD, MPH Columbia University Harlem Hospital New York.
Global HIV/AIDS Initiatives in Zambia: Issues of Harmonisation, Systems Capacity and Marginalised Groups Scale-up in the context of Systems Capacity Frontiers.
Hellen Muttai, MBChB, MPH Clinical Care Manager
Integration of TB and HIV Services: Experiences from the Kericho District Hospital Charles S. Kiptemas, MBChB, MPH Director South Rift Valley HIV Care.
Cross-sectional assessment of patient outcomes using a systematic file review process Ambereen Jaffer, Gesine Meyer-Rath, Malebo Maponyane, Aimee Malingan,
The operational impact of new World Health Organization (WHO) antiretroviral treatment (ART) guidelines on HIV patient volume and program costs in Kisumu.
Delphine Sculier, MD,MPH Stop TB Department World Health Organisation Geneva, Switzerland Update on the revision of ART guidelines for TB patients.
Nurse Led Clinics Opportunity for nurses to make a difference Wilma Scholte op Reimer, RN, PhD Amsterdam School of Health Professions Academic Medical.
Hit and Miss: A Study of Post-Release Support Brendan Quinn and Amy Kirwan 23 rd June 2009.
Asthma in Minnesota Slide Set Asthma Program Minnesota Department of Health January 2013.
Presented by: National Forum for Heart Disease and Stroke Prevention Improving Hypertension Control The Kaiser Permanente Hypertension Control Project:
HYPnet Late presentation of vertically transmitted HIV infection in adolescence A Judd 1, R Ferrand 2,3, E Jungmann 2, C Foster 4, H Lyall 4, Brian Rice.
Circumcision Status and HIV Infection among Black and Latino MSM in 3 US Cities Gregorio A Millett Centers for Disease Control Division of HIV/AIDS Prevention.
HIV and Aging Kathleen K Casey, MD Director, AIDS Ambulatory Care Center Jersey Shore University Medical Center.
Click the arrows to advance forward and backward. Click the Next link below to advance to the assessment. The A B C & D’s of Suicide Assessment and Clinical.
KZN STUDY –UPDATE South African ART Resistance Cohort Studies (SARCS)
Women and HIV Lucille Sanzero Eller, PhD, RN Associate Professor Rutgers, The State University of New Jersey College of Nursing A Local Performance Site.
Census, Mapping and Demographic Survey in an Urban Area of Uganda Jennifer Davis University of California, San Francisco, MS4.
Absorption, Retention and Empowerment
Mortality Among a Tuberculosis Outbreak Los Angeles County, 2007–2013 Brian Baker, MD Amit Chitnis, MD MPH Leslie Henry, BSN RN PHN 48th CTCA Educational.
PMTCT FAILURE: THE ROLE OF MATERNAL AND FACILITY –RELATED FACTORS ICASA Presentation 8 th to 12 th Dec 2013 Onono Maricianah 1, Elizabeth A. Bukusi 1,
Antiretroviral therapy eligibility at enrollment and time to treatment initiation in Ethiopia Chloe A. Teasdale 1, Chunhui Wang 1, Sileshi Lulseged 1,
Urgent need to strengthen active tracing of lost to follow up cases: a prospective cohort study of newly diagnosed HIV clients in rural districts, Zambia.
Retention across the continuum of care in a cohort of HIV infected children in rural India G. Alvarez-Uria RDT Hospital, Department of Infectious Diseases,
Most deaths among children enrolled in two program settings in Cambodia occur within the first 6 months after enrolment. Early mortality rates were more.
Primary Healthcare Facilities Deliver More Effective Antiretroviral Therapy: An Evaluation in Four Provinces in South Africa Geoffrey Fatti, Ashraf Grimwood.
Effects of patient tracing on estimates of lost to follow-up, mortality and retention in antiretroviral therapy programs in low-middle income countries:
Decentralization of HIV care and treatment services in Central Province, Kenya: Adult patient characteristics and outcomes Presenting author: William Reidy,
Matthew Fox Center for Global Health & Development Department of Epidemiology Boston University July 17, 2011 The first step is admitting you have a problem.
Risk factors for late-stage HIV disease presentation at initial HIV diagnosis in Durban, South Africa Paul K. Drain, Elena Losina, Senica Chetty, Gary.
Effectiveness of Micronutrient-rich Lipid Nutrient Supplements in Delaying Clinical Progression of HIV in Malawian Adults Heidi Sandige, MD.
Challenges of service integration: the TB model Linda-Gail Bekker The Desmond Tutu HIV Centre, Faculty of Health Sciences, University of Cape Town, South.
The Effect of Quality Improvement on Racial Disparities in Diabetes Care Thomas D. Sequist, MD MPH Alyce S. Adams, PhD Fang Zhang, MS Dennis Ross-Degnan,
Transition Program of HIV-infected adolescents to Adult HIV care in Buenos Aires, Argentina S. Arazi Caillaud 1, D. Mecikovsky 1, A.Bordato.
Management and Development for Health (MDH)
Factors Associated with Survival in HIV-Infected African Patients on Antiretroviral Therapy: The Impact of a Sampling-Based Approach to Address Losses.
Kuala Lumpur, Malaysia, 30 June - 3 July 2013 Outcomes of newly diagnosed HIV- infected patients referred to care after Provider Initiated.
Adverse Outcomes After Hospitalization and Delirium in Persons with Alzheimer Disease Charles Wang, PharmD Candidate.
HIV Testing in Medical Settings Mark Thrun, MD Denver Public Health
Outcomes of Antiretroviral Treatment Programs in Rural Lesotho: Health Centers and Hospitals Compared Niklaus Labhardt, Motlalepula Sello, Mamokone A.
Mövenpick Royal Palm Hotel Dar es Salaam, Tanzania August 4-6, 2009 The 7th Annual Track 1.0 ART Program Meeting.
Response to Antiretroviral Treatment In an Ethiopian Hospital Samuel Hailemariam, MD, MPH; J Allen McCutchan, MD, MSc Meaza Demissie, MD, PMH, PHD; Alemayehu.
Successfully enrolled in HIV Care but not linked to timely Treatment: Poor retention and Monitoring of Pre-ART patients who are not yet eligible for ART.
Retention in an antiretroviral program in the Democratic Republic of Congo Kalenga Lucien Koole Olivier Menten Joris Kiumbu Modeste Robin Ryder Mukumbi.
Screening for hypertension and diabetes at the time of HIV testing in Umlazi Township, Durban, South Africa Ingrid V. Bassett, Ting Hong, Paul Drain, Sabina.
Priscilla Tsondai, Lynne Wilkinson, Anna Grimsrud, Angelina Trivino,
Men are absent across the HIV continuum of care in a rural area of southern Mozambique Laura Fuente-Soro, Elisa Lopez-Varela, Orvalho Augusto , Charfudin.
Earlier treatment and lower mortality in infants Initiating ART at
Daniel Meressa, M.D. Global Health Committee St. Peter’s Hospital
L.F. Jefferys1, J. Hector1, M.A. Hobbins2, J. Ehmer2, N. Anderegg3
Cross-sectional assessment of patient outcomes using a systematic file review process: Results from 12,987 patient files Ambereen Jaffer, Gesine Meyer-Rath,
Better Retention Rates Observed in Patients on Lopinavir than Atazanavir in Uganda
Dorina Onoya1, Tembeka Sineke1, Alana Brennan1,2, Matt Fox1,2
Community patient tracking by Lay Community Health Workers (CHWs) is an effective strategy towards the 2nd & 3rd 90 Morapedi Boitumelo M.
Knowing your epidemic and knowing your response – maximising routinely collected data to measure and monitor HIV epidemics in sub-Saharan Africa Monitoring.
Extended ART Initiation Criteria Can Be Implemented Successfully in Rural South Africa Sarah Jane Steele1, Gemma Arellano2, Tom Ellman3, Amir Shroufi1,
24 July 2018 Treatment outcomes with bedaquiline use when substituted for second-line injectables in multidrug resistant tuberculosis: a retrospective.
Management and Development for Health (MDH)
Presentation transcript:

St Marys Hospital Ingrid V. Bassett, MD, MPH Massachusetts General Hospital Harvard Medical School May 25, 2010 Who Starts ART in Durban, South Africa? …Not Everyone Who Should

Conflict of Interest Disclosure Ingrid V. Bassett, MD, MPH Has no real or apparent conflicts of interest to report

Overview 2.9 million on ART in sub-Saharan Africa, but 6.7 million need it How much of this gap is due to failure to link to care after a new HIV diagnosis? What can be done to improve linkage? WHO, 2009

Road Map Retention versus Linkage Linkage in resource-limited settings Durban, South Africa study Strategies to improve Linkage

Poor retention well-documented Systematic review sub-Saharan Africa of adult patient retention in ART programs Non-research ART programs, patient cohorts (>74,000 patients) Very high rates of loss ~40% not in care at 2 years: Loss to follow-up 56% Death 40% Rosen, PLos Medicine, 2007

Background: Poor retention substantial during scale-up Updated systematic review >226,000 patients, 39 cohorts, 80% in Afr ~25% lost at 2 years, ~35% lost at 3 years Slightly better than before, but still substantial losses after ART initiation Routine M+E and PEPFAR reporting focus on ART patients Fox, Trop Med & Intl Health, 2010

Retention On ART

Linkage What is known about rates of linkage to HIV care after a new HIV diagnosis? What are risk factors for failing to enter care? Do these differ by setting? HIV TestCD4 count Training 1,2,3 On ART Psychosocial Assessment

Determinants of mortality and non- death losses: Cape Town Community-based ART program, enrolled in ART program 121 died (46% pre-tx; 40% early tx) Risk: symptomatic disease and CD4 <100 After first year of ART, low mortality rate <1%/year High risk of pre-ART and early ART deaths Lawn, AIDS, 2006

What is rate of mortality and retention pre-ART in Uganda? TASO ART Clinic, Jinja, rural Uganda Focus on 4-8 week pre-ART screening period 26% of ART-eligibles did not finish screening Risk: lower median CD4, male gender Increased over time with clinic expansion Home visits to ascertain status 30% on ART with different provider 25% alive and not on ART (44% due to transport) 28% died 17% LTFU High rate of pre-ART mortality Amuron, BMC Public Health, 2009

Why failing to link in Malawi? Cross-sectional study Rural Malawi (MSF), Defaulters missed appointment by >1 mo 874 adults pre-ART traced, 71% found: 51% dead, most within 3 months of last visit Reasons for defaulting: stigma, dissatisfaction with care/staff, perceived improved health, transport costs McGuire, Trop Med & Intl Health, 2010

From HIV test through ART start in Mozambique: a retrospective study Routine care data from 2 HIV care networks HIV tested , first year after free ART in public sector 7005 with HIV Only 56% enrolled ART clinic within 30d 1506 ART-eligible Only 31% start ART within 90d of CD4 Micek, JAIDS, 2009

Failure to Link: Open questions What proportion of newly identified HIV- infected dont start ART? What are the risk factors for failing to link to care? Few prospective data about losses and mortality before HIV clinic entry Valuable to design interventions to improve linkage to HIV care

Who Starts ART in Durban, South Africa? …Not Everyone Who Should Ingrid V. Bassett, MD, MPH Susan Regan, PhD Senica Chetty, MSc Janet Giddy, MBChB, MFamMed Lauren M. Uhler, BA Helga Holst, MD, MBA Douglas Ross, MBChB, MBA Rochelle P. Walensky, MD, MPH Kenneth A. Freedberg, MD, MSc Elena Losina, PhD St Marys Hospital

Background: HIV in South Africa > 5 million people HIV-infected Largest ART program in the world Only ~40% of HIV-infected who need ART are receiving it Few data why HIV-infected fail to link to care WHO 2009; PEPFAR 2008; Lawn, AIDS, 2008

Objectives To evaluate rates of ART initiation within 12 months of a positive HIV test in Durban, South Africa To identify baseline factors that predict failure to be on ART at 1 year

Methods: Two Study Sites Prospective, observational cohort Sites: Outpatient departments in Durban McCord (urban) St. Marys Mariannhill (semi-rural) Partially government subsidized Patients pay a fee for care PEPFAR-funded HIV clinics

Methods: Study population Adults (18y) English or Zulu speaking Enrolled prior to rapid HIV test Enrolled November 2006-October 2008 Follow-up through June 2009

Methods: Data collection Baseline enrollment interview 6, 12 month questionnaire Domains: demographic, geographic, clinical Electronic medical record review at enrollment site: CD4, ART start

Methods: Two Outcomes 1) Obtaining CD4 count within 90 days 2) ART initiation within 12 months for eligible patients CD4 200 /µl within 90 days of HIV test ART initiation at study site documented in medical record

Methods: Data analysis Predictors of failing to initiate ART evaluated with multivariate logistic regression Kaplan-Meier curve of time to ART initiation Mortality pre- and post-ART initiation

Enrolled 2,775 HIV-negative 1,308 HIV-infected 1,467 HIV Test No test/result: 71 Indeterminate: 6 54% HIV prevalence Screened 3,401 Results: Cohort enrollment Bassett, AIDS, 2010

HIV-infected cohort characteristics Female 54% Median age 34 yrs (IQR 28-41) Median follow-up time12 mos (IQR 8-14) Follow up available 70% Bassett, AIDS, 2010

HIV-infected 1,467 CD4 count within 90 days Yes 607 No 862 CD4<200/μl 368 CD4200/μl % no CD4 within 90 days Results: CD4 count within 90 days 61% CD4<200/µl ART eligible at baseline Unknown 2 Bassett, AIDS, 2010

HIV Tested* HIV+ CD4/results Eligible for ART Start ART *Screened 11/06-10/08, enrolled in study and have known HIV status 368 How many start ART? Failure to obtain CD4 Failure to start ART when eligible Bassett, AIDS, ,775 1,467

Results: Long delay from HIV diagnosis to ART start P<0.001 Males: 40% started ART by 6 months Females: 55% started ART by 6 months Bassett, AIDS, 2010 days P<0.001

Results: Predictors of failure to start ART within 12 months Male gender RR 1.5 ( ) No HIV+ family/friendRR 5.1 ( ) Adjusting for: age, CD4 count, prior HIV test, work outside the home Bassett, AIDS, 2010

Results: High rate of mortality 15% of HIV-infected cohort (216 deaths/1,467) 21% of ART eligible cohort (76 deaths/368) % dead HIV+ cohort with CD4 P<0.001 CD4 (/µl) strata Bassett, AIDS, 2010

High rate of mortality pre-ART Most patients died pre-ART or with unknown ART status P<0.001 CD4 (/µl) strata Overall Pre-ART % dead HIV+ cohort with CD4 Bassett, AIDS, 2010

Limitations Sites may not be representative of public sector hospitals in South Africa 30% of pre-ART patients were unreachable Likely underestimates mortality and ART initiation that occurred at non-study sites Bassett, AIDS, 2010

Study conclusions Substantial pre-ART loss along care path Men less likely to initiate ART Severe immune suppression at diagnosis Long delays to ART initiation High rates of pre-ART mortality Bassett, AIDS, 2010

Implications Promote early HIV diagnosis and care Monitor mortality and losses pre-ART Improve access for men Interventions needed to improve linkage to care/minimize delays Following new HIV diagnosis After ART eligibility determined

Learning from on-ART strategies: patient tracking 2 ART facilities Lilongwe, Malawi, Patients who missed clinic appt >3 weeks 2,653 patients identified, 85% traced by phone and home visit 30% died 1,158 found alive, not transferred 74% returned to clinic (women, age >39 at ART start) Tweya, Trop Med & Int Hlth, 2010

Learning from on-ART strategies Patient tracers phone calls or home visits to ascertain vital status, help subjects return to care Proactive adherence support, including home visits, community-based collaborations Transportation vouchers Eliminate co-pays Reliable (electronic) monitoring Geng, JAMA, 2008; Ochieng, IAS, 2007; Tweya, Trop Med & Intl Health, 2010; Rosen, Trop Med & Intl Health, 2010; Etienne, Trop Med & Intl Health, 2010; Forster, Bull WHO,2008

Learning from on-ART strategies: efficiency Johannesburg 4-month pilot study of telephone tracing by social worker Average $432/patient returned to care Lessons learned from this and others: Maintain updated contact information Capacity to know about clinic transfers Capacity to access national death registry Rosen, Trop Med & Intl Health, 2010 Bassett, JAIDS, 2009; Mwanaga, CROI, 2008;Tweya, Trop Med & Intl Health, 2010;

Learning from US linkage to care trial HIV-infected, recently diagnosed, multi-site US RCT case management vs standard of care Primary outcome in-care at 12 months A higher proportion in intervention arm visited HIV clinician at least once within 6 months (78% versus 60%, p < 0.01) and at least twice within 12 months (64% versus 49%, p < 0.01) No similar RCT has yet been performed in resource-limited settings Gardner, AIDS, 2005

Upcoming NIMH-funded linkage to care trial Multi-site RCT in Durban starting in 2010 Assess clinical impact and cost- effectiveness of a health system navigator assigned in the outpatient setting Navigator in-person, SMS, phone contacts Evaluate linkage to HIV care and TB treatment completion

Acknowledgements Durban Team Janet Giddy Senica Chetty Douglas Ross Lindeni Sangweni Aletta Maphasa Success Mncwabe Yolisa Mgobhozi Bongiwe Mdadane Matilda Mazibuko Helga Holst Study participants at McCord and St. Marys Hospitals, Durban US Team and Funders Rochelle Walensky Ken Freedberg Elena Losina Susan Regan Sarah Bancroft Harv Univ Program on AIDS Harvard CFAR AI60354 NIAID K23 AI Harvard Catalyst Grant Upcoming trial: NIMH R01 MH090326

St Marys Hospital